This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Tumor Metabolism
joint with Metabolism and Angiogenesis
Organizer(s): William G. Kaelin, Jr., Benjamin F. Cravatt III and Peter K. Jackson
Date: March 16 - 21, 2014
Location: Whistler Conference Centre, Whistler, BC, Canada
Sponsored by Bayer HealthCare Pharmaceuticals, Pfizer Inc., Takeda Pharmaceutical Company Limited and TESARO, Inc. Supported by an educational donation provided by Amgen.
Summary of Meeting:
The recent discovery of mutations affecting metabolic enzymes such as succinate dehydrogenase, fumarate hydratase and isocitrate dehydrogenase provides genetic evidence that altered cellular metabolism can cause cancer. Moreover, it has become apparent that a number of proteins that regulate processes pertinent to cellular transformation, such as enzymes that affect chromatin structure, respond to specific cellular metabolites. Finally, technologies for monitoring cellular metabolism are improving rapidly including technologies that lend themselves to non-invasive imaging. The goals of this meeting are to bring together a diverse group of scientists from academia and industry with basic and translational interests surrounding cancer metabolism. A particular focus will be on metabolic enzymes as potential targets for treating and/or imaging cancer cells. Toward this end this meeting engages a diverse group of scientists including biologists, chemists and engineers. This meeting provides participants with a greater understanding of the language and logic of cellular metabolism and provides a sense of the translational opportunities emerging from our growing knowledge of the role that altered metabolism plays in cancer.
Scholarship Deadline: November 18 2013
Discounted Abstract Deadline: November 18 2013
Abstract Deadline: December 17 2013
Discounted Registration Deadline: January 15 2014
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Educational donation provided by AmgenBayer HealthCare PharmaceuticalsPfizer Inc.Takeda Pharmaceutical Company LimitedTESARO, Inc.
We gratefully acknowledge additional support for this conference from:
Cell Signaling Technology, Inc.Seahorse Bioscience, Inc.
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Eli Lilly and Company
We gratefully acknowledge the generous grant for this conference provided by:

National Cancer Institute (NCI)
Grant No. 1R13CA183152-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found